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A vast  diversity  of  microbes  including  macrofungi  remain  untapped  for valuable  bioac-
tivities  including  antimicrobial  activity.  Searching  wild  sources  may  bring  novel  natural
products  with  antimicrobial  properties  that can  provide  protection  against  infectious  dis-
eases. The  present  study  was  designed  to identify  the diverse  forms  of  mushrooms  being
used  as  an ethnomycological  source  of food  and  medicine  by the  tribes  of  Meghalaya,
India,  and  microscopically  study  the structures  of mushrooms  along  with  observing  their
antimicrobial  effects  on pathogens.  Fruiting  bodies  of  mushrooms  were  viewed  morpho-
logically  and  microscopically,  and  were  identiﬁed  using  molecular  markers.  The  dried  aerial
parts  of the fruiting  bodies  were  extracted  with methanol  and screened  for  their antimi-
crobial activity  using  2,3,-triphenyl  tetrazolium  chloride  against  two Gram-negative  and
two Gram-positive  bacteria.  The  average  diameter  of  the  inhibitory  zone  induced  by  fungal
extracts  ranged  from  9 mm  to  22 mm  for Gram-negative  and  from  16  mm  to  24  mm  for
Gram-positive  bacteria,  indicating  that  this  dietary  source  is  a good  antimicrobial  agent.
Mushroom  structures  were  examined  using  optical  microscopy,  while  the  deformities  on
the  pathogens  inﬂicted  by  mushroom  extracts  were  visualized  using  scanning  electron
microscopy,  which  showed  accumulation  and  formation  of  bioﬁlm  in Gram-positive  and
shrinkage with  cavity  formation  in  Gram-negative  bacteria.
© 2016  Saudi  Society  of  Microscopes.  Published  by  Elsevier  Ltd.  All  rights  reserved.. Introduction
Infectious diseases remain one of the major concerns
or humankind since the 20th century. Development of
esistance by clinical pathogens against a wide range
f antibiotics is a global issue. Infections by multidrug-
esistant clinical isolates of Escherichia coli, Staphylococcus
ureus,  and Klebsiella pneumoniae are a major drive to
timulate the search of novel biological samples as antimi-
robial agents [1].
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213-879X/© 2016 Saudi Society of Microscopes. Published by Elsevier Ltd. All riAlthough a wide spectrum of antibiotics produced by
fungi, including penicillin, streptomycin, cephalosporin,
griseofulvin, erythromycin, and rifamycin, are used com-
mercially, antibiotics from imperfect fungi are scarcely
documented. Imperfect fungi or macrofungi have been
used as a source of food and medicine since the Roman and
Greek times [2,3]. The ﬁrst ever report of basidiomycetes
being used as a source of antimicrobial agent was  ﬁrst
reported by Anchel et al. [4]. The mycelium and the fruiting
body contain a wide range of bioactive compounds that can
be used for their antimicrobial properties. Besides the cell
wall glucans and secondary metabolites, basidiomycetes
are also known to contain phenolic compounds, ﬂavonoids,
triterpenoids, lectin, dietary ﬁbers, terpenes, and alkaloids,
which have been proven to show signiﬁcant bioactivi-
ties against microbial infections and anti-inﬂammatory,
ghts reserved.
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antiviral, anticancer, cardiovascular, and gastrointestinal
disorders along with immunomodulatory properties [5–7].
The methanolic extract of polyporus mushrooms such
as Ganoderma luciderm, Phellinus rimosus, and Navesporous
ﬂoccose is known to show antibacterial activity against
a wide spectrum of clinical isolates [8]. As reported by
Belsare et al. [9], chloroform and methanolic extracts of
Phellinus switeniae showed potent activity against Acineto-
bacter baumannii.
Since multidrug resistance of pathogenic microorgan-
isms has been rampant due to the extensive use of
commercial drugs for treatment of infectious diseases,
there is a need for potent novel antimicrobial sources that
can act against a wide range of clinical pathogens. The
local tribal communities of Northeast India use mushrooms
as a source of food rather than as a source of medicine.
The present study aims to identify the diverse range of
basidiomycetes that are predominant in the local subtrop-
ical forest of Northeast India and to screen them for their
antimicrobial potential against the most common clini-
cal pathogenic bacteria. This study also tried to correlate
the electron micrographs of the subcellular ultrastruc-
tural deformities in pathogens induced by the mushroom
extracts.
2. Materials and methods
2.1. Sampling location
Five mushroom species were collected from the forest
of Meghalaya (25◦26.7′N and 91◦44.92′E) at an altitude of
1788 m with 75% humidity.
2.2. Sample collection and processing
Mushroom samples were collected in separate sterile
bags and brought to the laboratory. These samples were
washed gently with double-distilled water to remove the
dirt, while maintaining complete safety by using ster-
ile gloves and mask. Morphological identiﬁcation of wild
macrofungi was performed freshly according to both phe-
notypic and microscopic characteristics, following the
standard parameters and online key [10]. A part of the
collection was preserved in formaldehyde with the soft tis-
sue in 2% formaldehyde and leathery in 4% formaldehyde
solution in glass jars and stored in the in-house culture col-
lection of the parent university. The remaining parts were
shade dried for 3–4 days, wrapped with aluminum foil, and
stored at –20 ◦C for further analysis.
2.3. Optical microscopic examination
Small pieces of the pileus were cut from the fruit body
and were mounted on a cover slip over a ﬁlter paper.
The plate was immediately covered with a lid. The spore
print was observed after 24 hours on the surface of the
ﬁlter paper. The spores were observed under microscope
using two different dyes: lactophenol cotton blue and
Melzer’s reagent (0.5 g of iodine, 1.5 of potassium iodide,
22 g of chloral hydrate, and 20 g of water). Melzer’s staining and Ultrastructure 4 (2016) 203–210
reaction was used for detecting amyloid, pseudoamyloid,
or nonamyloid of the spores [11].
2.4. Molecular characterization of the macrofungi
Freeze-dried fungal tissues were considered for
extraction of DNA. Genomic DNA was extracted using
HiPurA fungal DNA isolation kit (Himedia, Mumbai, India)
and characterized by two universal primers—ITS1F
(5′-TCCGTAGGTGAACCTGCGG-3′) and ITS4R (5′-
TCCTCCGCTTATTGATATGC-3′) [12]. Ampliﬁcation was
carried out in a GeneAmp 9700 thermal cycler (Applied
Biosystems, Foster City, California, USA) under the follow-
ing conditions: initial denaturation at 95 ◦C for 5 minutes;
35 cycles of denaturation at 9 ◦C for 1 minute, annealing at
52 ◦C for 30 seconds, extension at 72 ◦C for 1 minute; and
a ﬁnal extension at 72 ◦C for 10 minutes. The ampliﬁed
Polymerase Chain Reaction products were electrophoret-
ically analyzed on 1.5% agarose gel along with a 100 bp
marker ladder. Ampliﬁed ITS ribotypes were puriﬁed using
the QIAquick gel extraction kit (Qiagen, Hilden, Germany)
according to the manufacturer’s protocol. All the puriﬁed
amplicons were sequenced (Xcelris Lab, Ahmedabad,
India).
2.5. Sequence and phylogenetic analysis
The sequences were searched for similarity with other
deposited sequences in the National Center for Biotechnol-
ogy Information (NCBI) database. The aligned sequences
were computed using ClustalW software and sequence
homologies were determined using a Basic Local Alignment
Search Tool (BLAST) search to create an evolutionary dis-
tance matrix using MEGA 6 software. The sequences were
submitted to NCBI and accession numbers were obtained.
2.6. Preparation of crude aqueous methanolic extract
The fruiting body was separated, washed with double-
distilled water to remove dirt, oven dried at 40 ◦C, and
powdered using a mortar and pestle. Ten grams of ﬁne
powder were mixed with 70% methanol at room tempera-
ture with stirring at 150 rpm for 5 days. Methanol was then
evaporated to dryness under vacuum pressure at a temper-
ature of 45 ◦C in a rotary evaporator, to obtain the crude
extract of the macrofungi [13]. The dried biomaterial was
ﬁnally dissolved in dimethylsulfoxide (DMSO) at a stock
concentration of 1 mg/mL, which was further analyzed for
antimicrobial activity.
2.7. Antimicrobial assay by disc diffusion method
In vitro antimicrobial assay was carried out using the
disc diffusion method against two Gram-positive and two
Gram-negative bacterial pathogens, following the proto-
col of Katoch et al. [14] with minor modiﬁcations. The
bacterial strains Streptococcus pyogenes (MTCC1925), S.
aureus (MTCC96), K. pneumoniae (MTCC109), and E. coli
(MTCC730) were grown on brain–heart infusion at a tem-
perature of 37 ◦C for 18–24 hours until it reached a turbidity
of 0.5 McFarland standards (106 colony forming units/mL).
roscopy
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he antimicrobial assay was performed on Mueller Hin-
on Agar plates using a sterile susceptibility disc (Himedia),
 mm in diameter, into which 40 L of the crude methano-
ic extract and the pure extraction solvent (DMSO) as a
egative control were loaded separately. The plates were
reincubated at 4 ◦C for 1 hour for uniform diffusion. After
reincubation, all the plates were incubated at 37 ◦C for
4 hours. Chloramphenicol (30 g) was used as a positive
ontrol to determine the sensitivity of the strains. Antimi-
robial activity of the crude extracts was determined by
easuring the zone of inhibition around the sterile ﬁlter
aper disc.
.8. Minimum inhibitory concentration of the extracts
sing micro dilution technique
The minimum inhibitory concentration (MIC) of the
acrofungal extract was  determined in vitro using the
icrodilution technique in 96 multiwell microtiter plates,
ith minor modiﬁcations [15]. For susceptibility analy-
is, 50 L of the bacterial broth was distributed from the
econd to the 12th well in the plate (A2–A12). Stock concen-
ration (1 mg/mL) of the crude extract was further diluted
ith DMSO to reach a ﬁnal concentration of 25 mg/mL.
he crude extract of concentration 25 mg/mL  (100 L) was
dded into the ﬁrst row of the plate. To the rest of the
ells, serial dilution was performed using a micropipette
Fig. 1. Morphological features of mac and Ultrastructure 4 (2016) 203–210 205
(A2–A10). A single antimicrobial crude extract, in progres-
sive dilutions, was added to each of the wells. Then, 50 L
of the bacterial suspension of around 106 colony forming
units/mL was added to each well. Each plate has a set of
both growth in A11 and sterility control in A12. Plates were
covered with lids to avoid dehydration of the microbial
cells and were placed in an incubator at a growth condition
of 37 ◦C for 24 hours. After incubation, 10 L of 0.2% 2,3,5-
triphenyl tetrazoliumchloride was added in each well. The
microtiter plates with 2,3,5-triphenyl tetrazoliumchloride
were further incubated at the same temperature for 1
hour. A visible color change from purple to pink in 1 hour
indicated the growth of microbes and was  recorded as
a negative control. The MIC  of the macrofungal extract
was recorded as the lowest concentration that showed no
microbial growth.
2.9. Scanning electron microscopy
In order to analyze the morphological deformities of the
test bacteria under scanning electron microscopy (SEM),
the test organisms were treated with 4× concentration
of the MIC  of the macrofungal extract and were kept for
overnight incubation at 37 ◦C. At the end of the incubation,
bacterial cultures were washed three times with distilled
water and then ﬁxed with 2.5% glutaraldehyde in 0.1 M
cacodylate buffer (pH 7.3) for 4 hours. Glutaraldehyde was
rofungi selected in the study.
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Table 1
Macroscopic/microscopic features of the studied macrofungi.
Isolates Macroscopic/microscopic features
MBSRJ37 Cap: 2.5–6.5 cm broad, convex in young,
depressed shallow, green to olive green in the
center, dry leathery smooth surface
Stalk: 6 cm long, 1.5–2 cm thick, whitish,
brittle, smooth
Gills: whitish color continuous running down
the stem
Spores: 8.01–9.23 m × 4.01 m,  whitish
spore print, elliptical, dextrinoid in Melzer
MBSRJ44 Cap: polyporus up to 3.3 cm, semicircular with
wavy edges, leathery texture
Stalk: absent
Gills: absent
Pores: pale brownish
Spores: 3.75–3.67 m × 2.00 m,  whitish
spore print, oval to slightly allantoids,
dextrinoid
MBSRJ48 Cap: pale to dark brown, depressed in the
center, convex, scales are distinct, up to 3.6 cap
diameter, dry scaly surface
Stalk: 3.2 cm, dark brown to black toward the
end
Gills: whitish to pale brownish
Spores: 5.2 m × 2.88 m,  whitish spore print,
amyloid
MBSRJ51 Cap: 6.2 cm broad, hemispherical, ﬂat convex,
soft velvety, reddish yellow
Stalk: 6 cm long, 1–3 cm thick, swollen at the
base
Gills: absent
Pores: tubular, reddish yellow
Spores: 4.63–5.83 m,  brownish spore print,
inamyloid in Melzer
MBSRJ55 Cap: 9.6 cm broad, ﬂat convex, covered with
dusty ﬁbers, soft velvety, pale brownish at the
center, whitish at the edge
Stalk: 6–9.5 cm long, 1 cm thick, dark brown at
the base
Gills: present, whitish in color
Spores: 3.58–3.67 m,  long elliptical whitish
spore print, dextrinoid in Melzer
drained off, and the bacterial pellets were subjected to
three consecutive 1-hour washes with 0.1 M cacodylate
buffer, followed by one wash with distilled water. The
samples were further dehydrated with a series of ace-
tone wash (30%, 50%, 70%, 80%, 90%, 95%, and 100%), and
then the cells were immersed in trimethylsilane for twice
at a time interval of 10–15 minutes after every wash at
4 ◦C and brought to room temperature for drying. Finally,
the samples were sputter coated with a thin layer of
gold–palladium and scanned under SEM (JSM-6360; Jeol,
Peabody, Massachusetts, USA).
3. Results
3.1. Isolation and identiﬁcation
A total of ﬁve macrofungi with different morpho-
logical, sporological, and molecular traits were screened
(Figure 1). The phenotypic trait such as the macrofungal
color, shape, size of the pileus and stalk, color, texture
of the spore (Table 1) was used for tentative identiﬁca-
tion of the macrofungi. Microscopic analysis of the spores and Ultrastructure 4 (2016) 203–210
was  conducted to determine whether they are amyloid,
dextrinoid, and inamyloid in nature (Figure 2). Molecular
characterization of the conserve region of the macrofungi
to amplify rDNA-ITS region was considered to be the con-
ﬁrmatory identiﬁcation where the sequence data were
aligned using BLAST, and the macrofungi were found to
be the closest homolog of Russula variata, Trichaptum bio-
forme, Baorangia pseudocalopus, Echinoderma aspera,  and
Micromphale foetidum (Figure 3). The ITS sequence for the
macrofungi was  deposited to NCBI, and the accession num-
bers were obtained (KP843880, KP843882-KP843884, and
KP877447).
3.2. Antimicrobial assay
All the ﬁve voucher fungi showed antibacterial
efﬁcacy. The extract of the macrofungus T. bioforme
(MBSRJ44) showed the highest antimicrobial activity
against pathogenic microbes, followed by the extracts of
R. variata (MBSRJ37) and B. pseudocalopus (MBSRJ51). The
control disc with DMSO did not show any zone of inhibition
(Table 2).
3.3. MIC of crude extracts
All the crude extracts with antimicrobial activity were
further evaluated for their MIC  by the 96-well microdi-
lution technique. According to the primary antimicrobial
screening, the MIC  ranged from 0.195 mg/mL  to 25 mg/mL
against the tested strains. The MIC  value of the macro-
fungal extract of T. bioforme (MBSRJ44), which showed
an antagonistic effect against Gram-positive S. aureus,
was  0.195 mg/mL; this was  followed by the MIC  value
(0.78 mg/mL) of the macrofungal extract of B. pseudocalo-
pus (MBSRJ51) against S. pyogenes (Figure 4). The ﬁndings of
the MIC  values endorse the ﬁnding of the primary screening
using the disc diffusion technique. It is also evident from the
results that the macrofungal extract showed a more syn-
ergistic effect against Gram-positive bacteria than against
Gram-negative bacteria, which may  be attributed to the dif-
ference in the cell wall composition. The experiments were
repeated three times and the average MICs were obtained.
3.4. Scanning electron micrograph analysis
The extracts of the voucher fungi were found to possess
potent antibacterial effects against the pathogenic strains
and showed alteration of cell morphology, as revealed by
scanning electron micrographs. Control strains showed a
smooth, unrufﬂed regular surface, whereas strains treated
with the macrofungal extracts showed cavity formation,
and shrunken and distorted cell walls. Compounds in the
crude extracts were able to disrupt the intact cell mem-
brane of the strains, allowing the formation of cavities and
swelling, shrinkage, and leakage of intercellular compo-
nents. The healthy cells of K. pneumoniae have a regular
and smooth shape (Figure 5A), whereas the cells dam-
aged by the effect of the extracts were found to contain
bleb-like irregular protrusions with shrunken and aggluti-
nated inner compositions (Figures 5B–F). However, E. coli
did not reveal any physical deformities under the scanning
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lectron microscope (Figures 6A and 6B). The macrofungal
xtracts may  have certain irregularities in the metabolic
ctivities of E. coli. The control strain, Gram-positive
. aureus,  formed cell-to-cell smooth grape-like struc-
ures (Figure 7A), whereas the treated pathogens showed
Fig. 3. Evolutionary positions of macrofungi with their rela observed among mushrooms.
cellular deformities with sticky membrane and leakage
of the internal compositions (Figures 7B–D). The micro-
graph of the treated S. pyogenes revealed the formation
of bioﬁlm, cell agglutination, and discrete clumps that
were not seen in the case of control cells (Figures 8A
ted species based on rRNA-ITS sequence similarity.
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Table 2
Antimicrobial activity of the macrofungal extract against pathogenic microbes (inhibition zone in mm).
Isolates K. pneumoniae E. coli S. aureus S. pyogenes
MBSRJ37 10 25 14 13
MBSRJ44 12 26 22 11
MBSRJ48 17 10 15 9
MBSRJ51 21 16 8 8
MBSRJ55 17 16 10 10
 DMSO — —
The symbol “—”indicates no zone of inhibition.
DMSO = dimethylsulfoxide.
and 8B). The SEM micrograph of both Gram-negative and
Gram-positive bacteria on treatment with the macrofun-
gal extract showed perforation in the cell wall membrane
along with leakage of inner compositions.
4. Discussion
Subcellular deformities were examined using elec-
tron microscopy, which supports the hypothesis that
the extracts of higher fungi can be a potent source of
antimicrobial agents causing cellular deformities in clini-
cal pathogens. The ﬁndings of this study correlated with the
ﬁndings of Ozturk et al. [16] as the MIC  of the macrofun-
gal extract is more potent against Gram-positive bacteria
than against Gram-negative pathogens. However, the effect
was much more prominent in the morphology of Gram-
negative K. pneumoniae. Electron microscopy provided the
ultrastructural details of deformities in the cell architecture
Fig. 4. Inhibition of tested pathogens by the mushroom extracts, expressed as M
MIC  = minimum inhibitory concentration.— —
on treating the cells with the extracts. SEM micrographs
provided evidence of cell shrinkage and cell wall destruc-
tion. An increased number of antimicrobial agents from
macrofungi are anticipated, and the traditional use of
macrofungi by ethnic communities as a source of medicine
holds importance in this regard. All the macrofungi consid-
ered in the present study exhibited an antagonistic effect
against the tested clinical pathogens. The macrofungus
E. aspera demonstrated the highest antimicrobial activity,
which suggests that it can be explored as a potential source
of an antimicrobial agent.
Identiﬁcation of the macrofungi and their in vitro
activity provides favorable clinical evidence of their
use as antimicrobial agents. Visualization of the cellu-
lar deformities of treated clinical pathogens and their
scanning electron micrographs give a platform to under-
stand the nature of deformities and damages induced by
the fungal extracts on the pathogens. With increasing
IC.
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Fig. 5. (a—f) Scanning electron micrographs of untreated K. pneumoniae showing normal morphology (a) and those of the treated cells showing agglutination
(b)  of cellular components, cell wall breakage (c), leakage (d), cavity formation (e) and shrinkage of cellular components (f).
Fig. 6. (a and b) Scanning electron micrographs of normal (a) and treated E. coli showing no physical damages in the cellular structures (b).
Fig. 7. (a–d) Micrographs showing control (a) and treated cells of S. aureus with deformed cellular structure and leakage (b–d).
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[
[
[16] Ozturk M,  Emin Duru M,  Kivrak S, Mercan-Dogan N, Turkoglu A,Fig. 8. (a and b) Scanning electron micrographs of
resistance of clinical pathogens toward commercial antibi-
otics, methanolic extract of macrofungi holds promise as
a novel drug candidate in the modern era. The present
study brings out the ﬁrst report on macrofungi consumed
by ethnic tribes from Northeast India, which were surveyed
as potential antimicrobial agents and provide promising
observations.
Conﬂicts of interest
The authors declare no conﬂicts of interest.
Acknowledgments
The authors acknowledge the ﬁnancial support
received from the Department of Science and Technology
(SERB/SR/SO/PS/49/2012), Government of India, to carry
out the present work. They also thank Sophisticated Ana-
lytical Instrument Facility, North Eastern Hill University,
Shillong, for providing the SEM service.
References
[1] Thomson KS, Moland ES. Version 2000: the new blactamases of
Gram-negative bacteria at the dawn of the new millennium. Microb
Infect 2000;2:1225–35.
[2] Sagakami H, Aohi T, Simpson A, Tanuma S. Induction of immunopo-
tentiation activity by a protein-bound polysaccharide PSK. Anti-
cancer Res 1991;11:993–1000.
[3] Wasser SP, Weis AL. Medicinal properties of substances occurring in
higher Basidiomycetes mushrooms: current perspectives (review).
Int J Med  Mushrooms 1999;1:31–62.
[4] Anchel M,  Hervey A, Kavanagh F, Polatnick J, Robbins WJ.  Antibi-
otic substances from Basidiomycetes III. Caprius similis and Lentinus
degener. Proc Nat Acad Sc 1948;34:498–502.ed (a) and bioﬁlm forming treated S. pyogenes (b).
[5] Kim S, Fung DYC. Antibacterial effect of water-soluble arrowroot
(Puerariae radix) tea extracts on food borne pathogens in ground beef
and mushroom soup. J Food Prot 2004;67:1953–6.
[6] Akyuz M, Onganer AN, Erecevit P, Kirbag S. Antimicrobial activity
of  some edible mushrooms in the Eastern and Southeast Anatolia
Region of Turkey. Gazi Univ J Sci 2007;23:125–30.
[7] Barros L, Calhelha RC, Vaz JA, Ferreira ICFR, Bapista P, Estevinho
LM.  Antimicrobial activity and bioactive compounds of Portuguese
wild edible mushrooms methanolic extract. Eur Food Res Technol
2007;225:151–6.
[8] Sheena N, Ajith TA, Mathew A, Janardhanan KK. Antibacterial
activity of three macrofungi, Ganoderma lucidum, Navesporus ﬂoc-
cosa and Phellinus srimosus occurring in South India. Pharm Biol
2013;41:54–6.
[9] Belsare MH, Ranadive KR, Bapat GS, Garad S, Deokule SS, Vaidya JG.
Screening of mushroom Phellinus switeniae (Murr) S. Herrera and
Bondart against clinical isolates of Acinetobacter baumannii Bouvet
&  Grimont. Elixir Appl Botan 2013;54:12398–9.
10] Peterson JH, Gaba A, Laessøe T. Available at: http://www.mycokey.
com (accessed 12 August, 2015).
11] Kuo M.  Using a microscope: equipment. Retrieved from the
MushroomExpert.Com.  Web  site: http://www.mushroomexpert.com/
microscope equipment.html (accessed 18 July, 2013). 2006.
12] White TJ, Bruns T, Lee S, Taylor J. Ampliﬁcation and direct sequenc-
ing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA,
et  al., editors. PCR protocols, a guide to methods and applications.
San Diego, CA: Academic Press Publishers; 1990. p. 315–32.
13] Gbolagade JS, Fasidi IO. Antimicrobial activities of some selected
Nigerian mushrooms. Afr J Biomed Res 2005;8:83–7.
14] Katoch M,  Singh G, Sharma S, Gupta N, Sangwan PL, Saxena AK. Cyto-
toxic and antimicrobial activities of endophytic fungi isolated from
Bacoba monnieri (L.) Pennell (Scrophulariaceae). BMC  Complement
Altern Med 2014;14:52.
15] Nath A, Joshi SR. Ultrastructural effect on mastitis pathogens by the
extract of endophytic fungi associated with ethnoveterinary plant,
Hibiscus sabdariffa L. J Microsc Ultrastruct 2014;3:38–43.Ozler MA.  In vitro antioxidant, anticholinesterase and antimicrobial
activity studies on three Agaricus species with fatty acid composi-
tions an iron content: a comparative study on the three most edible
mushrooms. Food Chem Toxicol 2011;49:1353–60.
